Search results
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
Reuters via Yahoo Singapore Finance· 23 minutes agoTop executives from Bristol Myers Squibb, Johnson & Johnson, AbbVie and AstraZeneca, which have five...
Breast cancer drug not recommended for NHS use after price talks break down
PA Media: UK News via Yahoo News Singapore· 4 hours agoIt then paused its appraisal in December while commercial talks with pharmaceutical companies...
School mums bond over shared cancer journey
BBC via Yahoo News Singapore· 2 days agoIt added that without agreeing a price that represented a "cost-effective use of NHS resources" it could not recommend Enhertu, though said it was "open...
Eaton Vance Worldwide Health Sciences Fund's Strategic Moves in Q2 2024: Spotlight on ...
GuruFocus.com via Yahoo Singapore Finance· 4 days agoLilly and Co (NYSE:LLY), 7.54% in Novo Nordisk A/S (OCSE:NOVO B), 7% in UnitedHealth Group Inc...
AstraZeneca CEO: We're building '2 supply chains' to avoid impact of US-China tensions
Yahoo Finance· 4 days agoDespite growing tensions between the US and China, the global pharmaceutical industry continues to...
NICE's methodology means people with cancer aren't getting drugs - AstraZeneca's Sir Pascal Soriot...
Sky News via Yahoo News Singapore· 4 days agoThe chief executive of AstraZeneca has criticised a public health body for refusing to make one of...
AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare...
Benzinga via Yahoo Singapore Finance· 4 days agoOn Thursday, AstraZeneca Plc (NASDAQ:AZN) reported second-quarter sales of $12.94 billion, up 13%...
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong...
Benzinga via Yahoo Singapore Finance· 4 days agoOn Thursday, Sanofi SA (NASDAQ:SNY) reported a second-quarter business operating income of 2.8...
Astrazeneca: Q2 Earnings Snapshot
Associated Press Finance via Yahoo Singapore Finance· 4 days agoCAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday reported second-quarter net income of $1.93 billion. On a per-share basis, the Cambridge ...
AstraZeneca shares fall despite guidance raise as drugmaker warns on income
Investing.com via Yahoo Singapore Finance· 4 days agoInvesting.com – Shares of AstraZeneca (NASDAQ:AZN) (LON:AZN) dropped on Thursday after the company reported that other operating income is expected to "decrease substantially ...
